UNSPSC 85445204: The diagnosis of paraldehyde

In this classification, this covers the group of activities that yields a diagnosis of paraldehyde. Paraldehyde is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y47.3.

UNSPSC 85445204 The diagnosis of paraldehyde is a Commodity code, but the recent state and local procurement activity under this code does not reflect diagnostic testing or paraldehyde analysis. Instead, the opportunities tagged to this code involve diagnostic imaging systems, ultrasound equipment, and phlebotomy services—none of which align with the nominal scope of paraldehyde diagnosis. The mismatch suggests either a data-tagging error in the state and local procurement system or that the code is being applied inconsistently across jurisdictions. State and local governments are not currently soliciting paraldehyde diagnostic work under this code in the available records.

The three most recent opportunities reveal the actual purchasing activity: San Mateo County Medical Center issued an RFP on July 9, 2026, for a Picture Archiving and Communication System (PACS) with an August 7, 2026 response deadline, requiring enterprise-grade implementation integrated with Epic EHR to support 65,000 annual radiology studies; Collier County, Florida, posted a Notice of Intent on April 1, 2026, to single-source ultrasound equipment (KOSMOS platform with TORSO-ONE probe) from EchoNous, Inc., with a March 26, 2026 deadline to challenge the single-source designation; and the Albuquerque Police Department issued an RFB on January 26, 2026, for on-call phlebotomy technicians to provide 300 annual blood draws with a February 25, 2026 response deadline. The issuing bodies span county healthcare systems, county procurement offices, and municipal law enforcement. Geographic activity includes California, Florida, and New Mexico. Given the absence of paraldehyde-related solicitations, this code shows limited decision relevance for firms pursuing diagnostic chemistry or toxicology work.